Platelet-activating factor receptor develops airway hyperresponsiveness independently of airway inflammation in a murine asthma model

J Immunol. 2004 Jun 1;172(11):7095-102. doi: 10.4049/jimmunol.172.11.7095.

Abstract

Lipid mediators play an important role in modulating inflammatory responses. Platelet-activating factor (PAF) is a potent proinflammatory phospholipid with eosinophil chemotactic activity in vitro and in vivo. We show in this study that mice deficient in PAF receptor exhibited significantly reduced airway hyperresponsiveness to muscarinic cholinergic stimulation in an asthma model. However, PAF receptor-deficient mice developed an eosinophilic inflammatory response at a comparable level to that of wild-type mice. These results indicate an important role for PAF receptor, downstream of the eosinophilic inflammatory cascade, in regulating airway responsiveness after sensitization and aeroallergen challenge.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Asthma / etiology*
  • Asthma / pathology
  • Bronchial Hyperreactivity / etiology*
  • Bronchoalveolar Lavage Fluid / cytology
  • Cytokines / analysis
  • Disease Models, Animal
  • Female
  • Immunoglobulin E / blood
  • Leukotrienes / analysis
  • Lung / pathology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Platelet Activating Factor / pharmacology
  • Platelet Membrane Glycoproteins / physiology*
  • Receptors, G-Protein-Coupled / physiology*

Substances

  • Cytokines
  • Leukotrienes
  • Platelet Activating Factor
  • Platelet Membrane Glycoproteins
  • Receptors, G-Protein-Coupled
  • platelet activating factor receptor
  • Immunoglobulin E